Medtronic has recalled certain MiniMed insulin pumps due to cybersecurity risks, and will provide alternative pumps to the estimated 4,000 U.S. patients using the pumps, the Food and Drug Administration announced yesterday. The small computerized pumps deliver insulin to a patient throughout the day through a catheter implanted under the skin, and wirelessly connect to a meter and monitoring system that measure and track the patient’s blood glucose levels. FDA said someone other than a patient or care provider could connect wirelessly to the pump and change its settings or stop insulin delivery, leading to high or low blood sugar or a buildup of acids in the blood. The agency recommends health care providers review with patients who have a recalled device the recommended safety precautions while waiting for a replacement device. FDA also urges device manufacturers to monitor and assess cybersecurity vulnerability risk and “be proactive about disclosing vulnerabilities and mitigations to address them,” said Suzanne Schwartz, M.D., deputy director of the Office of Strategic Partnerships and Technology Innovation at FDA’s Center for Devices and Radiological Health.

Related News Articles

Headline
The Center for Internet Security last week began offering its Malicious Domain Blocking and Reporting ransomware protection service free to private hospitals…
Headline
The FBI has issued recommendations to help prevent and respond to Telephony Denial of Service (TDoS) attacks, which can make 911 call centers unavailable to…
Chairperson's File
As we forge ahead in 2021 facing a lot of uncertainty, there’s one thing we recognize: The COVID-19 pandemic will have a lasting effect on the health and well-…
Headline
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response yesterday released a comprehensive and valuable…
Headline
The Health Information Sharing and Analysis Center and AHA will host a Feb. 10 panel discussion on best practices to combat unlawful robocalls to hospitals. A…
Headline
President Trump yesterday signed into law a bill (H.R. 7898) containing provisions that require the Secretary of Health and Human Services to consider certain…